Potential Diabetic Cardiomyopathy Therapies Targeting Pyroptosis: A Mini Review

Overview

Journal Front Cardiovasc Med

Specialty Cardiology & Vascular Diseases

Date 2022 Sep 5

PMID 36061533

Authors

Yu Jia

Dongze Li

Jing Yu

Wenli Jiang

Xiaoyang Liao

Qian Zhao

Affiliations

Soon will be listed here.

Abstract

Pyroptosis is primarily considered a pro-inflammatory class of caspase-1- and gasdermin D (GSDMD)-dependent programmed cell death. Inflammasome activation promotes the maturation and release of interleukin (IL)-1β and IL-18, cleavage of GSDMD, and development of pyroptosis. Recent studies have reported that NLRP3 inflammasome activation-mediated pyroptosis aggravates the formation and development of diabetes cardiomyopathy (DCM). These studies provide theoretical mechanisms for exploring a novel approach to treat DCM-associated cardiac dysfunction. Accordingly, this review aims to summarize studies that investigated possible DCM therapies targeting pyroptosis and elucidate the molecular mechanisms underlying NLRP3 inflammasome-mediated pyroptosis, and its potential association with the pathogenesis of DCM. This review may serve as a basis for the development of potential pharmacological agents as novel and effective treatments for managing and treating DCM.

Citing Articles

Non-coding RNAs affecting NLRP3 inflammasome pathway in diabetic cardiomyopathy: a comprehensive review of potential therapeutic options.

Radmehr E, Yazdanpanah N, Rezaei N J Transl Med. 2025; 23(1):249.

PMID: 40022088 PMC: 11871836. DOI: 10.1186/s12967-025-06269-w.

Molecular Basis of Cardiomyopathies in Type 2 Diabetes.

Giardinelli S, Meliota G, Mentino D, DAmato G, Faienza M Int J Mol Sci. 2024; 25(15).

PMID: 39125850 PMC: 11313011. DOI: 10.3390/ijms25158280.

Diabetic Cardiomyopathy and Cell Death: Focus on Metal-Mediated Cell Death.

Cai L, Tan Y, Holland B, Wintergerst K Cardiovasc Toxicol. 2024; 24(2):71-84.

PMID: 38321349 PMC: 11517829. DOI: 10.1007/s12012-024-09836-7.

Hydrogen sulfide plays an important role by regulating endoplasmic reticulum stress in myocardial diseases.

Zhao H, Fu X, Zhang Y, Yang Y, Wang H Front Pharmacol. 2023; 14:1172147.

PMID: 37124222 PMC: 10133551. DOI: 10.3389/fphar.2023.1172147.

Exogenous 8-hydroxydeoxyguanosine attenuates doxorubicin-induced cardiotoxicity by decreasing pyroptosis in H9c2 cardiomyocytes.

Hwang S, Kim S, Yoo K, Chung M, Lee J, Son K BMC Mol Cell Biol. 2022; 23(1):55.

PMID: 36517746 PMC: 9753270. DOI: 10.1186/s12860-022-00454-1.

References

Elmadbouh I, Singla D . BMP-7 Attenuates Inflammation-Induced Pyroptosis and Improves Cardiac Repair in Diabetic Cardiomyopathy. Cells. 2021; 10(10). PMC: 8533936. DOI: 10.3390/cells10102640. View

Zhang H, Chen X, Zong B, Yuan H, Wang Z, Wei Y . Gypenosides improve diabetic cardiomyopathy by inhibiting ROS-mediated NLRP3 inflammasome activation. J Cell Mol Med. 2018; 22(9):4437-4448. PMC: 6111804. DOI: 10.1111/jcmm.13743. View

Sen Z, Jie M, Jingzhi Y, Dongjie W, Dongming Z, Xiaoguang C . Total Coumarins from Protect against Cisplatin-Induced Acute Kidney Damage in Mice by Suppressing Renal Inflammation and Apoptosis. Evid Based Complement Alternat Med. 2017; 2017:5350161. PMC: 5358452. DOI: 10.1155/2017/5350161. View

Li C, Zhang J, Xue M, Li X, Han F, Liu X . SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart. Cardiovasc Diabetol. 2019; 18(1):15. PMC: 6359811. DOI: 10.1186/s12933-019-0816-2. View

Wilding J, Fernando K, Milne N, Evans M, Ali A, Bain S . SGLT2 Inhibitors in Type 2 Diabetes Management: Key Evidence and Implications for Clinical Practice. Diabetes Ther. 2018; 9(5):1757-1773. PMC: 6167302. DOI: 10.1007/s13300-018-0471-8. View

Mai L, Wen W, Qiu M, Liu X, Sun L, Zheng H . Association between prediabetes and adverse outcomes in heart failure. Diabetes Obes Metab. 2021; 23(11):2476-2483. DOI: 10.1111/dom.14490. View

Cookson B, Brennan M . Pro-inflammatory programmed cell death. Trends Microbiol. 2001; 9(3):113-4. DOI: 10.1016/s0966-842x(00)01936-3. View

Rajabi H, Ahmadi M, Aslani S, Saberianpour S, Rahbarghazi R . Exendin-4 as a Versatile Therapeutic Agent for the Amelioration of Diabetic Changes. Adv Pharm Bull. 2022; 12(2):237-247. PMC: 9106955. DOI: 10.34172/apb.2022.025. View

Zhang H, Ye Y, Zhao Z, Li K, Du Y, Hu Q . Neuroprotective effects of gypenosides in experimental autoimmune optic neuritis. Int J Ophthalmol. 2017; 10(4):541-549. PMC: 5406630. DOI: 10.18240/ijo.2017.04.07. View

10.

Abdelhalim M, Moussa S, Qaid H, Al-Ayed M . Potential effects of different natural antioxidants on inflammatory damage and oxidative-mediated hepatotoxicity induced by gold nanoparticles. Int J Nanomedicine. 2018; 13:7931-7938. PMC: 6260143. DOI: 10.2147/IJN.S171931. View

11.

Liu Q, Zhang F, Zhang X, Cheng R, Ma J, Yi J . Fenofibrate ameliorates diabetic retinopathy by modulating Nrf2 signaling and NLRP3 inflammasome activation. Mol Cell Biochem. 2017; 445(1-2):105-115. DOI: 10.1007/s11010-017-3256-x. View

12.

Wu Z, Luo J, Shi X, Zhang S, Zhu X, Guo J . Icariin alleviates rheumatoid arthritis via regulating miR-223-3p/NLRP3 signalling axis. Autoimmunity. 2020; 53(8):450-458. DOI: 10.1080/08916934.2020.1836488. View

13.

Rochette L, Ghibu S, Muresan A, Vergely C . Alpha-lipoic acid: molecular mechanisms and therapeutic potential in diabetes. Can J Physiol Pharmacol. 2015; 93(12):1021-7. DOI: 10.1139/cjpp-2014-0353. View

14.

Van Linthout S, Spillmann F, Riad A, Trimpert C, Lievens J, Meloni M . Human apolipoprotein A-I gene transfer reduces the development of experimental diabetic cardiomyopathy. Circulation. 2008; 117(12):1563-73. DOI: 10.1161/CIRCULATIONAHA.107.710830. View

15.

Cecchi S, Bennet S, Arora M . Bone morphogenetic protein-7: Review of signalling and efficacy in fracture healing. J Orthop Translat. 2018; 4:28-34. PMC: 5986999. DOI: 10.1016/j.jot.2015.08.001. View

16.

Zhao T, Kim K, Shin K, Park H, Kim H, Lee K . Gypenosides ameliorate memory deficits in MPTP-lesioned mouse model of Parkinson's disease treated with L-DOPA. BMC Complement Altern Med. 2017; 17(1):449. PMC: 5585899. DOI: 10.1186/s12906-017-1959-x. View

17.

Frustaci A, Kajstura J, Chimenti C, Jakoniuk I, Leri A, Maseri A . Myocardial cell death in human diabetes. Circ Res. 2000; 87(12):1123-32. DOI: 10.1161/01.res.87.12.1123. View

18.

Ghafouri-Fard S, Shoorei H, Mohaqiq M, Majidpoor J, Moosavi M, Taheri M . Exploring the role of non-coding RNAs in autophagy. Autophagy. 2021; 18(5):949-970. PMC: 9196749. DOI: 10.1080/15548627.2021.1883881. View

19.

Wei H, Bu R, Yang Q, Jia J, Li T, Wang Q . Exendin-4 Protects against Hyperglycemia-Induced Cardiomyocyte Pyroptosis via the AMPK-TXNIP Pathway. J Diabetes Res. 2019; 2019:8905917. PMC: 6925927. DOI: 10.1155/2019/8905917. View

20.

Wiviott S, Raz I, Bonaca M, Mosenzon O, Kato E, Cahn A . Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med. 2018; 380(4):347-357. DOI: 10.1056/NEJMoa1812389. View